Previous studies involving mice models of cardiac pressure overload (e.g., transverse aortic constriction, TAC) and neonatal injury have shown that the blockade of CCR2− macrophages using an antibody against macrophage colony-stimulating factor 1 receptor enhances cardiac fibrosis and blunts angiogenesis. This evidence concerns the gene CCR2 and persistent truncus arteriosus.